- Home
- / Journey Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Journey Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.7
2024-10-29
Market Capitalization
$125.9 M
2024-10-29
Revenue
$61.9 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 63.1M | 73.7M | 79.2M | 56.1M | 61.9M |
| Cost of goods sold | 32.1M | 30.8M | 26.7M | 20.9M | 20.9M |
| Gross profit | 42.9M | 52.5M | 35.3M | 40.9M | |
| Gross profit margin, % | 58.2% | 66.3% | 62.8% | 66.2% | |
| General and administrative expense | 39.8M | 59.5M | 43.9M | 40.2M | 44.4M |
| Operating expense total | 65.9M | 70.4M | 54.6M | 48.9M | 49.1M |
| Depreciation and amortization | 4.3M | ||||
| EBIT | (34.9M) | (27.5M) | (2.1M) | (13.7M) | (8.2M) |
| EBIT margin, % | -37.4% | -2.6% | -24.4% | -13.2% | |
| Interest expense | 7.0M | 2.0M | 1.7M | 2.0M | 3.7M |
| Pre tax profit | (42.4M) | (29.6M) | (3.6M) | (14.6M) | (11.4M) |
| Income tax expense | 1.6M | 63.0K | 221.0K | 61.0K | 60.0K |
| Net Income | (44.0M) | (29.6M) | (3.9M) | (14.7M) | (11.4M) |
| EPS | (1.7) | (0.2) | (0.7) | (0.5) |